Patents by Inventor Hisashi Kai

Hisashi Kai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7538526
    Abstract: A switching regulator includes a first switching element for charging an inductor, a switching circuit for discharging the inductor, a controller circuit for generating a first control signal for controlling the level of an output voltage of the switching regulator, and a reverse current suppressing circuit for controlling the on-resistance of the switching circuit based on whether a reverse current is detected in the switching regulator. A circuit and method for controlling the switching regulator are also disclosed.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: May 26, 2009
    Assignee: Ricoh Company, Ltd.
    Inventors: Shinichi Kojima, Hisashi Kai
  • Publication number: 20070120548
    Abstract: A switching regulator includes a first switching element for charging an inductor, a switching circuit for discharging the inductor, a controller circuit for generating a first control signal for controlling the level of an output voltage of the switching regulator, and a reverse current suppressing circuit for controlling the on-resistance of the switching circuit based on whether a reverse current is detected in the switching regulator. A circuit and method for controlling the switching regulator are also disclosed.
    Type: Application
    Filed: November 21, 2006
    Publication date: May 31, 2007
    Inventors: Shinichi Kojima, Hisashi Kai
  • Publication number: 20060122214
    Abstract: An agent for the prophylaxis and treatment of vascular constriction is provided, which contains a compound having a Rho kinase inhibitory activity. In particular, a compound having a Rho kinase inhibitory activity, for example, (+)-trans-4-(1-aminoethyl)-1-(4-pyridylcarbamoyl)cyclohexane, suppresses regenerative intima proliferation after disorder of blood vessel and has various other actions. Therefore, it is useful as an agent for the prophylaxis and treatment of vascular constriction, specifically, an agent for the prophylaxis and treatment of vascular constriction induced by disorder of vascular wall, such as vascular restenosis that occurs after an operation of percutaneus transluminal coronary angioplasty, vascular restenosis that occurs after an operation of percutaneus transluminal angioplasty, vascular constriction that occurs after vascular reconstruction, such as DCA, operation of intravascular indwelling of stent and the like, and vascular constriction that occurs after organ transplantation.
    Type: Application
    Filed: October 25, 2005
    Publication date: June 8, 2006
    Inventors: Hisashi Kai, Masayoshi Uehata